MERLONI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 524
EU - Europa 136
AS - Asia 62
AF - Africa 22
OC - Oceania 1
Totale 745
Nazione #
US - Stati Uniti d'America 524
IT - Italia 35
SG - Singapore 33
SE - Svezia 31
IE - Irlanda 27
CN - Cina 24
CI - Costa d'Avorio 17
DE - Germania 11
GB - Regno Unito 11
UA - Ucraina 11
FR - Francia 8
MA - Marocco 5
IN - India 3
DK - Danimarca 2
AU - Australia 1
JP - Giappone 1
KR - Corea 1
Totale 745
Città #
Chandler 86
Des Moines 81
Fairfield 42
Ashburn 39
Dublin 26
Jacksonville 26
New York 26
Wilmington 24
Boardman 23
Seattle 19
Abidjan 17
Houston 16
Singapore 15
Cambridge 13
Woodbridge 11
Ann Arbor 10
Lawrence 10
Princeton 10
San Mateo 9
Turin 7
Beijing 6
Falls Church 5
London 4
Washington 4
Cantu 3
Norwalk 3
Pune 3
San Diego 3
Caserta 2
Castelraimondo 2
Dallas 2
Kilburn 2
Recanati 2
Ancona 1
Bolton 1
Brisbane 1
Civitanova Marche 1
Cupra Marittima 1
Dangan 1
Handan 1
Hefei 1
Jiaxing 1
Los Angeles 1
Mestre 1
Nanjing 1
Osimo 1
Qingdao 1
San Costanzo 1
Shaoxing 1
Sioux Falls 1
Southwark 1
Wuhan 1
Wuxi 1
Totale 571
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 93
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 92
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic 92
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 88
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 75
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 73
Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase 71
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 64
Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience 57
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 57
Totale 762
Categoria #
all - tutte 4.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 2 0 1 1 1 5 8 11
2020/2021153 6 10 32 14 16 9 2 11 9 13 19 12
2021/202292 3 10 1 1 3 15 7 4 14 7 9 18
2022/2023272 19 25 15 23 10 101 0 9 44 1 18 7
2023/2024119 21 2 8 4 17 42 2 4 0 1 0 18
2024/202578 41 20 11 4 2 0 0 0 0 0 0 0
Totale 762